Additionally, overexpression of histone methyltransferase EZH2 can contribute to tumor-intrinsic ICI resistance by impairing antigen presentation, as well as by promoting the upregulation of PD-L1 expression on melanoma cells [70]. The gene discussed is PRDM9; the disease is melanoma.